Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Nature Microbiology

Volumn 5, Issue 4, 2020, Pages 562-569

  Letko, Michael ^a   Marzi, Andrea ^a   Munster, Vincent ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; MICROSOMAL AMINOPEPTIDASE; CORONAVIRUS SPIKE GLYCOPROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL PEPTIDASE IV; DPP4 PROTEIN, HUMAN; FUSION PROTEIN; S PROTEIN, SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS; SPIKE GLYCOPROTEIN, COVID-19 VIRUS; TRYPSIN; VIRUS RECEPTOR;

ALPHACORONAVIRUS; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BETACORONAVIRUS; BHK CELL LINE; CHIMERA; CONTROLLED STUDY; FUNCTIONAL ASSESSMENT; HOST CELL; HUMAN; HUMAN CELL; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOTYPING; RECEPTOR BINDING; SARS-RELATED CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRUS CELL INTERACTION; VIRUS ENTRY; WESTERN BLOTTING; ANIMAL; CELL LINE; CHEMISTRY; CLASSIFICATION; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; PROTEIN DOMAIN; SARS CORONAVIRUS;

ANIMALS; BETACORONAVIRUS; CD13 ANTIGENS; CELL LINE; DIPEPTIDYL PEPTIDASE 4; HUMANS; MUTATION; PEPTIDYL-DIPEPTIDASE A; PROTEIN DOMAINS; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; SARS VIRUS; SPIKE GLYCOPROTEIN, CORONAVIRUS; TRYPSIN; VIRUS INTERNALIZATION;

EID: 85079767277     PISSN: None     EISSN: 20585276     Source Type: Journal    
DOI: 10.1038/s41564-020-0688-y     Document Type: Article

References (37)

1. Wang, M. et al. SARS-CoV infection in a restaurant from palm civet. Emerg. Infect. Dis. 11, 1860–1865 (2005).
2. Kuiken, T. et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362, 263–270 (2003).
3. Li, W. et al. Bats are natural reservoirs of SARS-like coronaviruses. Science 310, 676–679 (2005).
4. Ge, X. Y. et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 503, 535–538 (2013).
5. Hu, B. et al. Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS Pathog. 13, e1006698 (2017).
6. Lau, S. K. et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl Acad. Sci. USA 102, 14040–14045 (2005).
7. Menachery, V. D. et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat. Med. 21, 1508–1513 (2015).
8. Li, F. Structure, function, and evolution of coronavirus spike proteins. Annu. Rev. Virol. 3, 237–261 (2016).
9. Simmons, G., Zmora, P., Gierer, S., Heurich, A. & Pohlmann, S. Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. Antiviral Res. 100, 605–614 (2013).
10. Matsuyama, S. et al. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J. Virol. 84, 12658–12664 (2010).
11. Bertram, S. et al. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J. Virol. 85, 13363–13372 (2011).
12. Belouzard, S., Chu, V. C. & Whittaker, G. R. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc. Natl Acad. Sci. USA 106, 5871–5876 (2009).
13. Raj, V. S. et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495, 251–254 (2013).
14. Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450–454 (2003).
15. Li, F., Li, W., Farzan, M. & Harrison, S. C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309, 1864–1868 (2005).
16. Becker, M. M. et al. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc. Natl Acad. Sci. USA 105, 19944–19949 (2008).
17. Marzi, A. et al. Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy. J. Infect. Dis. 204, S1066–S1074 (2011).
18. Millet, J. K. & Whittaker, G. R. Host cell proteases: critical determinants of coronavirus tropism and pathogenesis. Virus Res. 202, 120–134 (2015).
19. Yang, Y. et al. Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. Proc. Natl Acad. Sci. USA 111, 12516–12521 (2014).
20. Matsuyama, S., Ujike, M., Morikawa, S., Tashiro, M. & Taguchi, F. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc. Natl Acad. Sci. USA 102, 12543–12547 (2005).
21. Kam, Y. W. et al. Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro. PLoS ONE 4, e7870 (2009).
22. Yang, Y. et al. Two mutations were critical for bat-to-human transmission of Middle East respiratory syndrome coronavirus. J. Virol. 89, 9119–9123 (2015).
23. Menachery, V. D. et al. Trypsin treatment unlocks barrier for zoonotic bat coronaviruses infection. J. Virol. 94, e01774-19 (2020).
24. Beniac, D. R., deVarennes, S. L., Andonov, A., He, R. & Booth, T. F. Conformational reorganization of the SARS coronavirus spike following receptor binding: implications for membrane fusion. PLoS ONE 2, e1082 (2007).
25. Woo, P. C. et al. Molecular diversity of coronaviruses in bats. Virology 351, 180–187 (2006).
26. Anthony, S. J. et al. Further evidence for bats as the evolutionary source of Middle East respiratory syndrome coronavirus. mBio 8, e00373-17 (2017).
27. Shulla, A. et al. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J. Virol. 85, 873–882 (2011).
28. Adney, D. R. et al. Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels. Emerg. Infect. Dis. 20, 1999–2005 (2014).
29. Muth, D. et al. Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission. Sci. Rep. 8, 15177 (2018).
30. Hoffmann, M. et al. Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses. PLoS ONE 8, e72942 (2013).
31. Letko, M. et al. Adaptive evolution of MERS-CoV to species variation in DPP4. Cell Rep. 24, 1730–1737 (2018).
32. Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 10.1038/s41586-020-2012-7 (2020).
33. Wan, Y., Shang, J., Graham, R., Baric, R. S. & Li, F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J. Virol. 10.1128/JVI.00127-20 (2020).
34. Liao, C. L. & Lai, M. M. RNA recombination in a coronavirus: recombination between viral genomic RNA and transfected RNA fragments. J. Virol. 66, 6117–6124 (1992).
35. Graham, R. L. & Baric, R. S. Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. J. Virol. 84, 3134–3146 (2010).
36. Seifert, S. N. et al. Rousettus aegyptiacus bats do not support productive Nipah virus replication. J. Infect. Dis. 10.1093/infdis/jiz429 (2019).
37. Takada, A. et al. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl Acad. Sci. USA 94, 14764–14769 (1997).